Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Peeters

Showing results (141-150 of 250) with videos related to

Pageof 25
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cellsJ D Port, C C Debellis, J Klein, et al.
Journal of Epidemiology and Community Health|August 15, 2008
The relation between non-occupational physical activity and years lived with and without disabilityW J Nusselder, C W N Looman, O H Franco, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetesS A Peeters, L Engelen, J Buijs, et al.
Acta Neurologica Belgica|March 28, 1998
Peroneal nerve palsy in anorexia nervosaI Lutte, C Rhys, C Hubert, et al.
Cardiovascular Diabetology|September 30, 2015
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyStijn A Peeters, Lian Engelen, Jacqueline Buijs, et al.
Cardiovascular Diabetology|April 8, 2015
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyStijn A Peeters, Lian Engelen, Jacqueline Buijs, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Multiple dose pharmacokinetics of tiludronate in healthy volunteersH R Schwietert, P A Peeters, J Dingemanse, et al.
The American Journal of Physiology|April 1, 1995
Method for isolation of human ventricular myocytes from single endocardial and epicardial biopsiesG A Peeters, M C Sanguinetti, Y Eki, et al.
Clinical Biochemistry|July 10, 2021
A comparison of two different analytical methods for donor-derived cell-free DNA quantificationJeroen G H P Verhoeven, Carla C Baan, Annemiek M A Peeters, et al.
European Journal of Immunology|January 16, 2026
Shared HLA-E and Mamu-E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF- and Fluorescence Polarisation-Based MethodsMax N Quastel, Sashini A Ranawana, Bas W A Peeters, et al.
Pageof 25

Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Pharmacological characterization of chick and frog beta adrenergic receptors in primary cultures of myocardial cellsJ D Port, C C Debellis, J Klein, et al.
Journal of Epidemiology and Community Health|August 15, 2008
The relation between non-occupational physical activity and years lived with and without disabilityW J Nusselder, C W N Looman, O H Franco, et al.
Journal of Diabetes and Its Complications|February 4, 2018
Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetesS A Peeters, L Engelen, J Buijs, et al.
Acta Neurologica Belgica|March 28, 1998
Peroneal nerve palsy in anorexia nervosaI Lutte, C Rhys, C Hubert, et al.
Cardiovascular Diabetology|September 30, 2015
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyStijn A Peeters, Lian Engelen, Jacqueline Buijs, et al.
Cardiovascular Diabetology|April 8, 2015
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications StudyStijn A Peeters, Lian Engelen, Jacqueline Buijs, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Multiple dose pharmacokinetics of tiludronate in healthy volunteersH R Schwietert, P A Peeters, J Dingemanse, et al.
The American Journal of Physiology|April 1, 1995
Method for isolation of human ventricular myocytes from single endocardial and epicardial biopsiesG A Peeters, M C Sanguinetti, Y Eki, et al.
Clinical Biochemistry|July 10, 2021
A comparison of two different analytical methods for donor-derived cell-free DNA quantificationJeroen G H P Verhoeven, Carla C Baan, Annemiek M A Peeters, et al.
European Journal of Immunology|January 16, 2026
Shared HLA-E and Mamu-E Peptide Repertoires With Subtle Peptide Binding Differences Revealed by Combined nDSF- and Fluorescence Polarisation-Based MethodsMax N Quastel, Sashini A Ranawana, Bas W A Peeters, et al.
Pageof 25